New NICE TB guidance combines social and clinical aspects

NICE – the National Institute for Health and Care Excellence – has published updated guidance to better treat and prevent tuberculosis. For the first time, the guidance combines clinical advice and public health guidance in recognition of the importance of tackling the social aspects of TB alongside the clinical aspects of the illness. The guidance includes […]

Continue Reading

Quest for vaccine to beat TB by 2035

From a TB clinic in Cape Town, the Guardian reports on the quest for a new TB vaccine that lays at the heart of the Stop TB Partnership’s  new Global Plan to Stop TB ambition to end tuberculosis as a public health threat by 2035. Yoliswa Qaku, a mother from Cape Town, had her son […]

Continue Reading

World’s first child-friendly TB medication launched

TB Alliance and its partners have launched the World’s first child-friendly tuberculosis (TB) medications. The improved treatments are the first to meet child dosage guidelines set by the World Health Organization (WHO) in 2010. They are dispersible and palatable, simple to administer and affordable. At least 1 million children become ill with TB each year and […]

Continue Reading

Petition world leaders to end childhood TB

There’s a global health crisis: Tuberculosis (TB) kills nearly 400 children each day. It is the leading infectious cause of death worldwide – ahead of HIV. But kids with TB have remained neglected, uncounted, and untreated. But there’s new hope: More can be done. New and improved TB cures for children are on the way, and with a […]

Continue Reading

Fear factor – do we need to fear a disease to eliminate it?

A new Stop TB Partnership video highlights the limited knowledge people have about TB, especially in developed countries. The video takes a novel approach. Although TB is one of the deadliest diseases, people have forgotten about it, quite possibly because it’s been around for so long. So what if it was given a new name, like ILD […]

Continue Reading

Smoking shown to limit TB treatment success

Current smokers with pulmonary TB experience significantly worse treatment outcomes than smear positive non-smokers, researchers at the Taipei Medical University and Hospital have found. The study included 245 cases with cultures positive for TB and 114 controls with non-TB-related pulmonary diseases and negative sputum cultures. Current smokers had the highest failure rate (33%) for TB treatment, took longer […]

Continue Reading

Global Drug Facility promoting stability in TB drug supply

When individual countries try to purchase low-demand, specialty medicines – such as MDR-TB medicines – they are often unable to obtain consistent, affordable supplies. This leaves them vulnerable to price shocks, such as the recent hike in the price of MDR-TB drug Cycloserine. The Stop TB Partnership’s Global Drug Facility, however, is able to pool demand, […]

Continue Reading

Lord Kilpatrick of Kincraig, TB Alert Patron – Obituary

TB Alert is saddened by the passing of our Patron, Lord (Robert) Kilpatrick of Kincraig, who has died in Edinburgh at the age of 89. Lord Kilpatrick’s support for TB Alert was seeded in Edinburgh, where he was successfully treated for tuberculosis under the care of TB Alert’s founder and Honorary President, Sir John Crofton. […]

Continue Reading

Drug-price hikes don’t lead to better cures

Raising the price of out of patent drugs does not pay for new drug innovation, argues Médecins Sans Frontières’ Philipp du Cros in The Guardian, following controversy after the price of an anti-TB drug was increased 5000-fold. Cycloserine, which is used to treat multi-drug resistant TB, is one of two drugs that raised a furore this week […]

Continue Reading
MENU